STVN
Stevanato Group S.p.A.
Surgical & Medical Instruments & Apparatus
Best Medical Devices Stocks 2026 →
Stevanato Group S.p.A. (STVN) Stock: Buy, Sell, or Hold?
$13.53
-0.20 (-1.46%)
▼
5d:
-4.04%
30d:
-29.68%
90d:
-36.33%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (91%)
Quality Score
55/100
Position
OVERSOLD
30-Day Fair Range
$17.09 – $21.02
Position: OVERSOLD
Forward P/E & Valuation
18.7x
CHEAP
vs 22.6x historical avg
Wall Street Target
$19.46
+43.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$12.05 / $20.80
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: STVN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Get Alerted When STVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$21.00
Based on 5.1% avg growth
INTRINSIC VALUE TODAY
$13.04
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STVN is currently trading at $13.53, which is considered oversold relative to its 30-day fair value range of $17.09 to $21.02. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.7) compared to its historical average (22.6). Remarkably, the market is currently pricing in an annual earnings decline of 6.2% over the next few years. This pessimistic expectation contrasts with the company's recent 15.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, STVN is showing sideways momentum. Immediate support is located at $12.05, while resistance sits at $20.80.
Market Sentiment: STVN scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19.46 (+43.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, STVN is showing sideways momentum. Immediate support is located at $12.05, while resistance sits at $20.80.
Market Sentiment: STVN scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19.46 (+43.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$17.09 -
$21.02
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
Trading Range & Key Levels
30-Day Trading Range
$17.09 -
$21.02
Current vs Trading Range
OVERSOLD
Support Level
$12.05
Resistance Level
$20.80
Current Trend
Sideways
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 43.8% below Wall St target ($19.46)
- CAUTION: Bottoming setup, but lagging the sector by 12% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
18.67
Wall Street Target
$19.46
(+43.8%)
Revenue Growth (YoY)
7.6%
Earnings Growth (YoY)
15.4%
Profit Margin
11.2%
Valuation Discount vs History
-6.2% cheaper
PE vs Historical
18.7 vs 22.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.2%
(market-implied from PE analysis)
1-Year Target
$12.69
(-6%)
2-Year Target
$11.90
(-12%)
3-Year Target
$11.17
(-18%)
3-Yr Target (if PE normalizes)
(PE: 19→23)
$13.51
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 6.2%)
$17.23
(+27%)
Base:
(SPY PE: 18.7, Growth: 6.2%)
$16.20
(+20%)
Bear:
(PE: 15.9, Growth: 6.2%)
$13.77
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (23x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 23.27 | Current EPS (TTM): $0.59
Bull Case
$18.55
(+37%)
Analyst growth 22.8%, PE expands to 25.6
Base Case
$16.86
(+25%)
Market implied 22.8%, PE stable at 23.3
Bear Case
$9.34
(-31%)
Severe decline -20.0%, PE contracts to 19.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.7 to 22.6
Stabilization Target:
$16.38
(+21.0%)
PE Expansion Potential:
+21.0%
Share STVN Analysis
Share this live STVN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (STVN)
Bearish
1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Nov 3, 2026
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on STVN are bearish (sentiment score +0.00) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:50 AM ET
Data refreshes hourly during market hours. Next update: 8:50 AM
Data refreshes hourly during market hours. Next update: 8:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$486 | 39 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
21 analysts |
$203 | 65 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$82 | 27 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
16 analysts |
$471 | 52 HOLD |
|
RMD
ResMed Inc |
HOLD
20 analysts |
$264 | 52 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive STVN Research Pages
